IFC Holdings’s Quest Diagnostics DGX Stock Holding History

IFC Holdings’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,819	Closed	-$202K	–	522
2017 Q2	$202K	Buy	+1,819	New	+$192K	0.02%	463

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

IFC Holdings's DGX Position: Q3 2017 in Review

IFC Holdings sold out of Quest Diagnostics (DGX) in Q3 2017, closing a stake of 1,819 shares — an estimated $202K sold.

IFC Holdings first reported a position in DGX in Q2 2017 and held it in 1 quarter. The position peaked at $202K in Q2 2017. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

IFC Holdings reported no remaining Quest Diagnostics position as of Q3 2017 after selling out during the quarter.
IFC Holdings sold 1,819 Quest Diagnostics shares in Q3 2017, an estimated $202K.
IFC Holdings first reported a position in Quest Diagnostics in Q2 2017 and held it in 1 quarter.
IFC Holdings's Quest Diagnostics position peaked at $202K in Q2 2017.
616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on IFC Holdings's 13F filing for Q3 2017, filed 26 Oct 2017.